Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Sangeetha Reddy Miles C Andrews Patrick Hwu Vancheswaran Gopalakrishnan James P. Allison Zachary A. Cooper Alexander J. Lazar Jennifer Wargo |
| Publication date | January 17, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |